Global 503B Compounding Pharmacies Production, Demand and Key Producers, 2022-2028
This report studies the global 503B Compounding Pharmacies demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for 503B Compounding Pharmacies, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of 503B Compounding Pharmacies that contribute to its increasing demand across many markets.
The global 503B Compounding Pharmacies market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global 503B Compounding Pharmacies total market, 2017-2028, (USD Million)
Global 503B Compounding Pharmacies total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: 503B Compounding Pharmacies total market, key domestic companies and share, (USD Million)
Global 503B Compounding Pharmacies revenue by player and market share 2017-2022, (USD Million)
Global 503B Compounding Pharmacies total market by Type, CAGR, 2017-2028, (USD Million)
Global 503B Compounding Pharmacies total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global 503B Compounding Pharmacies market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Central Admixture Pharmacy Services, Nephron Pharmaceuticals Corporation, QuVa Pharma, Olympia Pharmacy, ASP Cares, Fagron Compounding Pharmacies, Athenex, Inc., Avella Specialty Pharmacy and Atlas Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World 503B Compounding Pharmacies market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global 503B Compounding Pharmacies Market, By Region:
1. How big is the global 503B Compounding Pharmacies market?
2. What is the demand of the global 503B Compounding Pharmacies market?
3. What is the year over year growth of the global 503B Compounding Pharmacies market?
4. What is the total value of the global 503B Compounding Pharmacies market?
5. Who are the major players in the global 503B Compounding Pharmacies market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for 503B Compounding Pharmacies, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of 503B Compounding Pharmacies that contribute to its increasing demand across many markets.
The global 503B Compounding Pharmacies market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global 503B Compounding Pharmacies total market, 2017-2028, (USD Million)
Global 503B Compounding Pharmacies total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: 503B Compounding Pharmacies total market, key domestic companies and share, (USD Million)
Global 503B Compounding Pharmacies revenue by player and market share 2017-2022, (USD Million)
Global 503B Compounding Pharmacies total market by Type, CAGR, 2017-2028, (USD Million)
Global 503B Compounding Pharmacies total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global 503B Compounding Pharmacies market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Central Admixture Pharmacy Services, Nephron Pharmaceuticals Corporation, QuVa Pharma, Olympia Pharmacy, ASP Cares, Fagron Compounding Pharmacies, Athenex, Inc., Avella Specialty Pharmacy and Atlas Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World 503B Compounding Pharmacies market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global 503B Compounding Pharmacies Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Acetaminophen
- Phenylephrine
- Midazolam
- Esmolol
- Vancomycin
- Epinephrine
- Adenocaine
- Fentanyl/ Bupivacaine
- Morphine
- Other
- On-line
- Offline
- Central Admixture Pharmacy Services
- Nephron Pharmaceuticals Corporation
- QuVa Pharma
- Olympia Pharmacy
- ASP Cares
- Fagron Compounding Pharmacies
- Athenex, Inc.
- Avella Specialty Pharmacy
- Atlas Pharmaceuticals
- Empower Pharmacy
- Carie Boyd’S Prescription Shop
- Edge Pharma, Imprimis NJOF
- IntegraDose Compounding services
- Wells Pharma of Houston, LLC
- US Compounding Inc.
- SCA Pharma
1. How big is the global 503B Compounding Pharmacies market?
2. What is the demand of the global 503B Compounding Pharmacies market?
3. What is the year over year growth of the global 503B Compounding Pharmacies market?
4. What is the total value of the global 503B Compounding Pharmacies market?
5. Who are the major players in the global 503B Compounding Pharmacies market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 503B Compounding Pharmacies Introduction
1.2 World 503B Compounding Pharmacies Market Size & Forecast (2017 & 2021 & 2028)
1.3 World 503B Compounding Pharmacies Total Market by Region
1.3.1 World 503B Compounding Pharmacies Market Size by Region (2017-2028)
1.3.2 United States 503B Compounding Pharmacies Market Size (2017-2028)
1.3.3 China 503B Compounding Pharmacies Market Size (2017-2028)
1.3.4 Europe 503B Compounding Pharmacies Market Size (2017-2028)
1.3.5 Japan 503B Compounding Pharmacies Market Size (2017-2028)
1.3.6 South Korea 503B Compounding Pharmacies Market Size (2017-2028)
1.3.7 ASEAN 503B Compounding Pharmacies Market Size (2017-2028)
1.3.8 India 503B Compounding Pharmacies Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 503B Compounding Pharmacies Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 503B Compounding Pharmacies Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD 503B COMPOUNDING PHARMACIES COMPANIES COMPETITIVE ANALYSIS
2.1 World 503B Compounding Pharmacies Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global 503B Compounding Pharmacies Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for 503B Compounding Pharmacies in 2021
2.2.3 Global Concentration Ratios (CR8) for 503B Compounding Pharmacies in 2021
2.3 503B Compounding Pharmacies Company Evaluation Quadrant
2.4 503B Compounding Pharmacies Market: Overall Company Footprint Analysis
2.4.1 503B Compounding Pharmacies Market: Region Footprint
2.4.2 503B Compounding Pharmacies Market: Company Product Type Footprint
2.4.3 503B Compounding Pharmacies Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: 503B Compounding Pharmacies Market Comparison
3.1.1 United States VS China: 503B Compounding Pharmacies Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: 503B Compounding Pharmacies Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States 503B Compounding Pharmacies Major Players and Market Share, 2017-2022
3.2.1 Major Players of 503B Compounding Pharmacies in United States, Headquarters (States, Country)
3.2.2 United States 503B Compounding Pharmacies Revenue by Domestic Player, (2017-2022)
3.3 China 503B Compounding Pharmacies Major Players and Market Share, 2017-2022
3.3.1 Major Players of 503B Compounding Pharmacies in China, Headquarters (Province, Country)
3.3.2 China 503B Compounding Pharmacies Revenue by Domestic Player, (2017-2022)
3.4 Rest of World 503B Compounding Pharmacies Major Players and Market Share, 2017-2022
3.4.1 Major Players of 503B Compounding Pharmacies in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World 503B Compounding Pharmacies Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World 503B Compounding Pharmacies Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Acetaminophen
4.2.2 Phenylephrine
4.2.3 Midazolam
4.2.4 Esmolol
4.2.5 Vancomycin
4.2.6 Epinephrine
4.2.7 Adenocaine
4.2.8 Fentanyl/ Bupivacaine
4.2.9 Morphine
4.2.10 Other
4.3 Market Segment by Type
4.3.1 World 503B Compounding Pharmacies Market Size by Type (2017-2022)
4.3.2 World 503B Compounding Pharmacies Market Size by Type (2023-2028)
4.3.3 World 503B Compounding Pharmacies Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World 503B Compounding Pharmacies Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 On-line
5.2.2 Offline
5.3 Market Segment by Application
5.3.1 World 503B Compounding Pharmacies Market Size by Application (2017-2022)
5.3.2 World 503B Compounding Pharmacies Market Size by Application (2023-2028)
5.3.3 World 503B Compounding Pharmacies Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Central Admixture Pharmacy Services
6.1.1 Central Admixture Pharmacy Services Details
6.1.2 Central Admixture Pharmacy Services Major Business
6.1.3 Central Admixture Pharmacy Services 503B Compounding Pharmacies Product and Services
6.1.4 Central Admixture Pharmacy Services 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Central Admixture Pharmacy Services Recent Developments/Updates
6.1.6 Central Admixture Pharmacy Services Competitive Strengths & Weaknesses
6.2 Nephron Pharmaceuticals Corporation
6.2.1 Nephron Pharmaceuticals Corporation Details
6.2.2 Nephron Pharmaceuticals Corporation Major Business
6.2.3 Nephron Pharmaceuticals Corporation 503B Compounding Pharmacies Product and Services
6.2.4 Nephron Pharmaceuticals Corporation 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Nephron Pharmaceuticals Corporation Recent Developments/Updates
6.2.6 Nephron Pharmaceuticals Corporation Competitive Strengths & Weaknesses
6.3 QuVa Pharma
6.3.1 QuVa Pharma Details
6.3.2 QuVa Pharma Major Business
6.3.3 QuVa Pharma 503B Compounding Pharmacies Product and Services
6.3.4 QuVa Pharma 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 QuVa Pharma Recent Developments/Updates
6.3.6 QuVa Pharma Competitive Strengths & Weaknesses
6.4 Olympia Pharmacy
6.4.1 Olympia Pharmacy Details
6.4.2 Olympia Pharmacy Major Business
6.4.3 Olympia Pharmacy 503B Compounding Pharmacies Product and Services
6.4.4 Olympia Pharmacy 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Olympia Pharmacy Recent Developments/Updates
6.4.6 Olympia Pharmacy Competitive Strengths & Weaknesses
6.5 ASP Cares
6.5.1 ASP Cares Details
6.5.2 ASP Cares Major Business
6.5.3 ASP Cares 503B Compounding Pharmacies Product and Services
6.5.4 ASP Cares 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 ASP Cares Recent Developments/Updates
6.5.6 ASP Cares Competitive Strengths & Weaknesses
6.6 Fagron Compounding Pharmacies
6.6.1 Fagron Compounding Pharmacies Details
6.6.2 Fagron Compounding Pharmacies Major Business
6.6.3 Fagron Compounding Pharmacies 503B Compounding Pharmacies Product and Services
6.6.4 Fagron Compounding Pharmacies 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Fagron Compounding Pharmacies Recent Developments/Updates
6.6.6 Fagron Compounding Pharmacies Competitive Strengths & Weaknesses
6.7 Athenex, Inc.
6.7.1 Athenex, Inc. Details
6.7.2 Athenex, Inc. Major Business
6.7.3 Athenex, Inc. 503B Compounding Pharmacies Product and Services
6.7.4 Athenex, Inc. 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Athenex, Inc. Recent Developments/Updates
6.7.6 Athenex, Inc. Competitive Strengths & Weaknesses
6.8 Avella Specialty Pharmacy
6.8.1 Avella Specialty Pharmacy Details
6.8.2 Avella Specialty Pharmacy Major Business
6.8.3 Avella Specialty Pharmacy 503B Compounding Pharmacies Product and Services
6.8.4 Avella Specialty Pharmacy 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Avella Specialty Pharmacy Recent Developments/Updates
6.8.6 Avella Specialty Pharmacy Competitive Strengths & Weaknesses
6.9 Atlas Pharmaceuticals
6.9.1 Atlas Pharmaceuticals Details
6.9.2 Atlas Pharmaceuticals Major Business
6.9.3 Atlas Pharmaceuticals 503B Compounding Pharmacies Product and Services
6.9.4 Atlas Pharmaceuticals 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 Atlas Pharmaceuticals Recent Developments/Updates
6.9.6 Atlas Pharmaceuticals Competitive Strengths & Weaknesses
6.10 Empower Pharmacy
6.10.1 Empower Pharmacy Details
6.10.2 Empower Pharmacy Major Business
6.10.3 Empower Pharmacy 503B Compounding Pharmacies Product and Services
6.10.4 Empower Pharmacy 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Empower Pharmacy Recent Developments/Updates
6.10.6 Empower Pharmacy Competitive Strengths & Weaknesses
6.11 Carie Boyd’S Prescription Shop
6.11.1 Carie Boyd’S Prescription Shop Details
6.11.2 Carie Boyd’S Prescription Shop Major Business
6.11.3 Carie Boyd’S Prescription Shop 503B Compounding Pharmacies Product and Services
6.11.4 Carie Boyd’S Prescription Shop 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Carie Boyd’S Prescription Shop Recent Developments/Updates
6.11.6 Carie Boyd’S Prescription Shop Competitive Strengths & Weaknesses
6.12 Edge Pharma, Imprimis NJOF
6.12.1 Edge Pharma, Imprimis NJOF Details
6.12.2 Edge Pharma, Imprimis NJOF Major Business
6.12.3 Edge Pharma, Imprimis NJOF 503B Compounding Pharmacies Product and Services
6.12.4 Edge Pharma, Imprimis NJOF 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 Edge Pharma, Imprimis NJOF Recent Developments/Updates
6.12.6 Edge Pharma, Imprimis NJOF Competitive Strengths & Weaknesses
6.13 IntegraDose Compounding services
6.13.1 IntegraDose Compounding services Details
6.13.2 IntegraDose Compounding services Major Business
6.13.3 IntegraDose Compounding services 503B Compounding Pharmacies Product and Services
6.13.4 IntegraDose Compounding services 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 IntegraDose Compounding services Recent Developments/Updates
6.13.6 IntegraDose Compounding services Competitive Strengths & Weaknesses
6.14 Wells Pharma of Houston, LLC
6.14.1 Wells Pharma of Houston, LLC Details
6.14.2 Wells Pharma of Houston, LLC Major Business
6.14.3 Wells Pharma of Houston, LLC 503B Compounding Pharmacies Product and Services
6.14.4 Wells Pharma of Houston, LLC 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 Wells Pharma of Houston, LLC Recent Developments/Updates
6.14.6 Wells Pharma of Houston, LLC Competitive Strengths & Weaknesses
6.15 US Compounding Inc.
6.15.1 US Compounding Inc. Details
6.15.2 US Compounding Inc. Major Business
6.15.3 US Compounding Inc. 503B Compounding Pharmacies Product and Services
6.15.4 US Compounding Inc. 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 US Compounding Inc. Recent Developments/Updates
6.15.6 US Compounding Inc. Competitive Strengths & Weaknesses
6.16 SCA Pharma
6.16.1 SCA Pharma Details
6.16.2 SCA Pharma Major Business
6.16.3 SCA Pharma 503B Compounding Pharmacies Product and Services
6.16.4 SCA Pharma 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 SCA Pharma Recent Developments/Updates
6.16.6 SCA Pharma Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of 503B Compounding Pharmacies and Key Manufacturers
7.2 503B Compounding Pharmacies Manufacturing Costs
7.3 503B Compounding Pharmacies Production Process
7.4 503B Compounding Pharmacies Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for 503B Compounding Pharmacies Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 503B Compounding Pharmacies Typical Distributors
8.3 503B Compounding Pharmacies Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 503B Compounding Pharmacies Introduction
1.2 World 503B Compounding Pharmacies Market Size & Forecast (2017 & 2021 & 2028)
1.3 World 503B Compounding Pharmacies Total Market by Region
1.3.1 World 503B Compounding Pharmacies Market Size by Region (2017-2028)
1.3.2 United States 503B Compounding Pharmacies Market Size (2017-2028)
1.3.3 China 503B Compounding Pharmacies Market Size (2017-2028)
1.3.4 Europe 503B Compounding Pharmacies Market Size (2017-2028)
1.3.5 Japan 503B Compounding Pharmacies Market Size (2017-2028)
1.3.6 South Korea 503B Compounding Pharmacies Market Size (2017-2028)
1.3.7 ASEAN 503B Compounding Pharmacies Market Size (2017-2028)
1.3.8 India 503B Compounding Pharmacies Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 503B Compounding Pharmacies Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 503B Compounding Pharmacies Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD 503B COMPOUNDING PHARMACIES COMPANIES COMPETITIVE ANALYSIS
2.1 World 503B Compounding Pharmacies Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global 503B Compounding Pharmacies Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for 503B Compounding Pharmacies in 2021
2.2.3 Global Concentration Ratios (CR8) for 503B Compounding Pharmacies in 2021
2.3 503B Compounding Pharmacies Company Evaluation Quadrant
2.4 503B Compounding Pharmacies Market: Overall Company Footprint Analysis
2.4.1 503B Compounding Pharmacies Market: Region Footprint
2.4.2 503B Compounding Pharmacies Market: Company Product Type Footprint
2.4.3 503B Compounding Pharmacies Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: 503B Compounding Pharmacies Market Comparison
3.1.1 United States VS China: 503B Compounding Pharmacies Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: 503B Compounding Pharmacies Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States 503B Compounding Pharmacies Major Players and Market Share, 2017-2022
3.2.1 Major Players of 503B Compounding Pharmacies in United States, Headquarters (States, Country)
3.2.2 United States 503B Compounding Pharmacies Revenue by Domestic Player, (2017-2022)
3.3 China 503B Compounding Pharmacies Major Players and Market Share, 2017-2022
3.3.1 Major Players of 503B Compounding Pharmacies in China, Headquarters (Province, Country)
3.3.2 China 503B Compounding Pharmacies Revenue by Domestic Player, (2017-2022)
3.4 Rest of World 503B Compounding Pharmacies Major Players and Market Share, 2017-2022
3.4.1 Major Players of 503B Compounding Pharmacies in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World 503B Compounding Pharmacies Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World 503B Compounding Pharmacies Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Acetaminophen
4.2.2 Phenylephrine
4.2.3 Midazolam
4.2.4 Esmolol
4.2.5 Vancomycin
4.2.6 Epinephrine
4.2.7 Adenocaine
4.2.8 Fentanyl/ Bupivacaine
4.2.9 Morphine
4.2.10 Other
4.3 Market Segment by Type
4.3.1 World 503B Compounding Pharmacies Market Size by Type (2017-2022)
4.3.2 World 503B Compounding Pharmacies Market Size by Type (2023-2028)
4.3.3 World 503B Compounding Pharmacies Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World 503B Compounding Pharmacies Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 On-line
5.2.2 Offline
5.3 Market Segment by Application
5.3.1 World 503B Compounding Pharmacies Market Size by Application (2017-2022)
5.3.2 World 503B Compounding Pharmacies Market Size by Application (2023-2028)
5.3.3 World 503B Compounding Pharmacies Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Central Admixture Pharmacy Services
6.1.1 Central Admixture Pharmacy Services Details
6.1.2 Central Admixture Pharmacy Services Major Business
6.1.3 Central Admixture Pharmacy Services 503B Compounding Pharmacies Product and Services
6.1.4 Central Admixture Pharmacy Services 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Central Admixture Pharmacy Services Recent Developments/Updates
6.1.6 Central Admixture Pharmacy Services Competitive Strengths & Weaknesses
6.2 Nephron Pharmaceuticals Corporation
6.2.1 Nephron Pharmaceuticals Corporation Details
6.2.2 Nephron Pharmaceuticals Corporation Major Business
6.2.3 Nephron Pharmaceuticals Corporation 503B Compounding Pharmacies Product and Services
6.2.4 Nephron Pharmaceuticals Corporation 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Nephron Pharmaceuticals Corporation Recent Developments/Updates
6.2.6 Nephron Pharmaceuticals Corporation Competitive Strengths & Weaknesses
6.3 QuVa Pharma
6.3.1 QuVa Pharma Details
6.3.2 QuVa Pharma Major Business
6.3.3 QuVa Pharma 503B Compounding Pharmacies Product and Services
6.3.4 QuVa Pharma 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 QuVa Pharma Recent Developments/Updates
6.3.6 QuVa Pharma Competitive Strengths & Weaknesses
6.4 Olympia Pharmacy
6.4.1 Olympia Pharmacy Details
6.4.2 Olympia Pharmacy Major Business
6.4.3 Olympia Pharmacy 503B Compounding Pharmacies Product and Services
6.4.4 Olympia Pharmacy 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Olympia Pharmacy Recent Developments/Updates
6.4.6 Olympia Pharmacy Competitive Strengths & Weaknesses
6.5 ASP Cares
6.5.1 ASP Cares Details
6.5.2 ASP Cares Major Business
6.5.3 ASP Cares 503B Compounding Pharmacies Product and Services
6.5.4 ASP Cares 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 ASP Cares Recent Developments/Updates
6.5.6 ASP Cares Competitive Strengths & Weaknesses
6.6 Fagron Compounding Pharmacies
6.6.1 Fagron Compounding Pharmacies Details
6.6.2 Fagron Compounding Pharmacies Major Business
6.6.3 Fagron Compounding Pharmacies 503B Compounding Pharmacies Product and Services
6.6.4 Fagron Compounding Pharmacies 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Fagron Compounding Pharmacies Recent Developments/Updates
6.6.6 Fagron Compounding Pharmacies Competitive Strengths & Weaknesses
6.7 Athenex, Inc.
6.7.1 Athenex, Inc. Details
6.7.2 Athenex, Inc. Major Business
6.7.3 Athenex, Inc. 503B Compounding Pharmacies Product and Services
6.7.4 Athenex, Inc. 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Athenex, Inc. Recent Developments/Updates
6.7.6 Athenex, Inc. Competitive Strengths & Weaknesses
6.8 Avella Specialty Pharmacy
6.8.1 Avella Specialty Pharmacy Details
6.8.2 Avella Specialty Pharmacy Major Business
6.8.3 Avella Specialty Pharmacy 503B Compounding Pharmacies Product and Services
6.8.4 Avella Specialty Pharmacy 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Avella Specialty Pharmacy Recent Developments/Updates
6.8.6 Avella Specialty Pharmacy Competitive Strengths & Weaknesses
6.9 Atlas Pharmaceuticals
6.9.1 Atlas Pharmaceuticals Details
6.9.2 Atlas Pharmaceuticals Major Business
6.9.3 Atlas Pharmaceuticals 503B Compounding Pharmacies Product and Services
6.9.4 Atlas Pharmaceuticals 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 Atlas Pharmaceuticals Recent Developments/Updates
6.9.6 Atlas Pharmaceuticals Competitive Strengths & Weaknesses
6.10 Empower Pharmacy
6.10.1 Empower Pharmacy Details
6.10.2 Empower Pharmacy Major Business
6.10.3 Empower Pharmacy 503B Compounding Pharmacies Product and Services
6.10.4 Empower Pharmacy 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Empower Pharmacy Recent Developments/Updates
6.10.6 Empower Pharmacy Competitive Strengths & Weaknesses
6.11 Carie Boyd’S Prescription Shop
6.11.1 Carie Boyd’S Prescription Shop Details
6.11.2 Carie Boyd’S Prescription Shop Major Business
6.11.3 Carie Boyd’S Prescription Shop 503B Compounding Pharmacies Product and Services
6.11.4 Carie Boyd’S Prescription Shop 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Carie Boyd’S Prescription Shop Recent Developments/Updates
6.11.6 Carie Boyd’S Prescription Shop Competitive Strengths & Weaknesses
6.12 Edge Pharma, Imprimis NJOF
6.12.1 Edge Pharma, Imprimis NJOF Details
6.12.2 Edge Pharma, Imprimis NJOF Major Business
6.12.3 Edge Pharma, Imprimis NJOF 503B Compounding Pharmacies Product and Services
6.12.4 Edge Pharma, Imprimis NJOF 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 Edge Pharma, Imprimis NJOF Recent Developments/Updates
6.12.6 Edge Pharma, Imprimis NJOF Competitive Strengths & Weaknesses
6.13 IntegraDose Compounding services
6.13.1 IntegraDose Compounding services Details
6.13.2 IntegraDose Compounding services Major Business
6.13.3 IntegraDose Compounding services 503B Compounding Pharmacies Product and Services
6.13.4 IntegraDose Compounding services 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 IntegraDose Compounding services Recent Developments/Updates
6.13.6 IntegraDose Compounding services Competitive Strengths & Weaknesses
6.14 Wells Pharma of Houston, LLC
6.14.1 Wells Pharma of Houston, LLC Details
6.14.2 Wells Pharma of Houston, LLC Major Business
6.14.3 Wells Pharma of Houston, LLC 503B Compounding Pharmacies Product and Services
6.14.4 Wells Pharma of Houston, LLC 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 Wells Pharma of Houston, LLC Recent Developments/Updates
6.14.6 Wells Pharma of Houston, LLC Competitive Strengths & Weaknesses
6.15 US Compounding Inc.
6.15.1 US Compounding Inc. Details
6.15.2 US Compounding Inc. Major Business
6.15.3 US Compounding Inc. 503B Compounding Pharmacies Product and Services
6.15.4 US Compounding Inc. 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 US Compounding Inc. Recent Developments/Updates
6.15.6 US Compounding Inc. Competitive Strengths & Weaknesses
6.16 SCA Pharma
6.16.1 SCA Pharma Details
6.16.2 SCA Pharma Major Business
6.16.3 SCA Pharma 503B Compounding Pharmacies Product and Services
6.16.4 SCA Pharma 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 SCA Pharma Recent Developments/Updates
6.16.6 SCA Pharma Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of 503B Compounding Pharmacies and Key Manufacturers
7.2 503B Compounding Pharmacies Manufacturing Costs
7.3 503B Compounding Pharmacies Production Process
7.4 503B Compounding Pharmacies Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for 503B Compounding Pharmacies Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 503B Compounding Pharmacies Typical Distributors
8.3 503B Compounding Pharmacies Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World 503B Compounding Pharmacies Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World 503B Compounding Pharmacies Market Size by Region (2017-2022) & (USD Million)
Table 3. World 503B Compounding Pharmacies Market Size by Region (2023-2028) & (USD Million)
Table 4. World 503B Compounding Pharmacies Market Size Market Share by Region (2017-2022)
Table 5. World 503B Compounding Pharmacies Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World 503B Compounding Pharmacies Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key 503B Compounding Pharmacies Players in 2021
Table 9. World 503B Compounding Pharmacies Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global 503B Compounding Pharmacies Company Evaluation Quadrant
Table 11. Head Office of Key 503B Compounding Pharmacies Player
Table 12. 503B Compounding Pharmacies Market: Company Product Type Footprint
Table 13. 503B Compounding Pharmacies Market: Company Product Application Footprint
Table 14. 503B Compounding Pharmacies Mergers & Acquisitions Activity
Table 15. United States VS China 503B Compounding Pharmacies Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of 503B Compounding Pharmacies in United States, Headquarters (States, Country)
Table 17. United States 503B Compounding Pharmacies Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States 503B Compounding Pharmacies Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of 503B Compounding Pharmacies in China, Company Headquarters (Province, Country)
Table 20. China 503B Compounding Pharmacies Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China 503B Compounding Pharmacies Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of 503B Compounding Pharmacies in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World 503B Compounding Pharmacies Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World 503B Compounding Pharmacies Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World 503B Compounding Pharmacies Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World 503B Compounding Pharmacies Revenue by Type (2017-2022) & (USD Million)
Table 27. World 503B Compounding Pharmacies Revenue by Type (2023-2028) & (USD Million)
Table 28. World 503B Compounding Pharmacies Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World 503B Compounding Pharmacies Revenue by Application (2017-2022) & (USD Million)
Table 30. World 503B Compounding Pharmacies Revenue by Application (2023-2028) & (USD Million)
Table 31. Central Admixture Pharmacy Services Basic Information, Area Served and Competitors
Table 32. Central Admixture Pharmacy Services Major Business
Table 33. Central Admixture Pharmacy Services 503B Compounding Pharmacies Product and Services
Table 34. Central Admixture Pharmacy Services 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Central Admixture Pharmacy Services Recent Developments/Updates
Table 36. Central Admixture Pharmacy Services Competitive Strengths & Weaknesses
Table 37. Nephron Pharmaceuticals Corporation Basic Information, Area Served and Competitors
Table 38. Nephron Pharmaceuticals Corporation Major Business
Table 39. Nephron Pharmaceuticals Corporation 503B Compounding Pharmacies Product and Services
Table 40. Nephron Pharmaceuticals Corporation 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Nephron Pharmaceuticals Corporation Recent Developments/Updates
Table 42. Nephron Pharmaceuticals Corporation Competitive Strengths & Weaknesses
Table 43. QuVa Pharma Basic Information, Area Served and Competitors
Table 44. QuVa Pharma Major Business
Table 45. QuVa Pharma 503B Compounding Pharmacies Product and Services
Table 46. QuVa Pharma 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. QuVa Pharma Recent Developments/Updates
Table 48. QuVa Pharma Competitive Strengths & Weaknesses
Table 49. Olympia Pharmacy Basic Information, Area Served and Competitors
Table 50. Olympia Pharmacy Major Business
Table 51. Olympia Pharmacy 503B Compounding Pharmacies Product and Services
Table 52. Olympia Pharmacy 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Olympia Pharmacy Recent Developments/Updates
Table 54. Olympia Pharmacy Competitive Strengths & Weaknesses
Table 55. ASP Cares Basic Information, Area Served and Competitors
Table 56. ASP Cares Major Business
Table 57. ASP Cares 503B Compounding Pharmacies Product and Services
Table 58. ASP Cares 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. ASP Cares Recent Developments/Updates
Table 60. ASP Cares Competitive Strengths & Weaknesses
Table 61. Fagron Compounding Pharmacies Basic Information, Area Served and Competitors
Table 62. Fagron Compounding Pharmacies Major Business
Table 63. Fagron Compounding Pharmacies 503B Compounding Pharmacies Product and Services
Table 64. Fagron Compounding Pharmacies 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Fagron Compounding Pharmacies Recent Developments/Updates
Table 66. Fagron Compounding Pharmacies Competitive Strengths & Weaknesses
Table 67. Athenex, Inc. Basic Information, Area Served and Competitors
Table 68. Athenex, Inc. Major Business
Table 69. Athenex, Inc. 503B Compounding Pharmacies Product and Services
Table 70. Athenex, Inc. 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Athenex, Inc. Recent Developments/Updates
Table 72. Athenex, Inc. Competitive Strengths & Weaknesses
Table 73. Avella Specialty Pharmacy Basic Information, Area Served and Competitors
Table 74. Avella Specialty Pharmacy Major Business
Table 75. Avella Specialty Pharmacy 503B Compounding Pharmacies Product and Services
Table 76. Avella Specialty Pharmacy 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Avella Specialty Pharmacy Recent Developments/Updates
Table 78. Avella Specialty Pharmacy Competitive Strengths & Weaknesses
Table 79. Atlas Pharmaceuticals Basic Information, Area Served and Competitors
Table 80. Atlas Pharmaceuticals Major Business
Table 81. Atlas Pharmaceuticals 503B Compounding Pharmacies Product and Services
Table 82. Atlas Pharmaceuticals 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Atlas Pharmaceuticals Recent Developments/Updates
Table 84. Atlas Pharmaceuticals Competitive Strengths & Weaknesses
Table 85. Empower Pharmacy Basic Information, Area Served and Competitors
Table 86. Empower Pharmacy Major Business
Table 87. Empower Pharmacy 503B Compounding Pharmacies Product and Services
Table 88. Empower Pharmacy 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Empower Pharmacy Recent Developments/Updates
Table 90. Empower Pharmacy Competitive Strengths & Weaknesses
Table 91. Carie Boyd’S Prescription Shop Basic Information, Area Served and Competitors
Table 92. Carie Boyd’S Prescription Shop Major Business
Table 93. Carie Boyd’S Prescription Shop 503B Compounding Pharmacies Product and Services
Table 94. Carie Boyd’S Prescription Shop 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Carie Boyd’S Prescription Shop Recent Developments/Updates
Table 96. Carie Boyd’S Prescription Shop Competitive Strengths & Weaknesses
Table 97. Edge Pharma, Imprimis NJOF Basic Information, Area Served and Competitors
Table 98. Edge Pharma, Imprimis NJOF Major Business
Table 99. Edge Pharma, Imprimis NJOF 503B Compounding Pharmacies Product and Services
Table 100. Edge Pharma, Imprimis NJOF 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Edge Pharma, Imprimis NJOF Recent Developments/Updates
Table 102. Edge Pharma, Imprimis NJOF Competitive Strengths & Weaknesses
Table 103. IntegraDose Compounding services Basic Information, Area Served and Competitors
Table 104. IntegraDose Compounding services Major Business
Table 105. IntegraDose Compounding services 503B Compounding Pharmacies Product and Services
Table 106. IntegraDose Compounding services 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. IntegraDose Compounding services Recent Developments/Updates
Table 108. IntegraDose Compounding services Competitive Strengths & Weaknesses
Table 109. Wells Pharma of Houston, LLC Basic Information, Area Served and Competitors
Table 110. Wells Pharma of Houston, LLC Major Business
Table 111. Wells Pharma of Houston, LLC 503B Compounding Pharmacies Product and Services
Table 112. Wells Pharma of Houston, LLC 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. Wells Pharma of Houston, LLC Recent Developments/Updates
Table 114. Wells Pharma of Houston, LLC Competitive Strengths & Weaknesses
Table 115. US Compounding Inc. Basic Information, Area Served and Competitors
Table 116. US Compounding Inc. Major Business
Table 117. US Compounding Inc. 503B Compounding Pharmacies Product and Services
Table 118. US Compounding Inc. 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. US Compounding Inc. Recent Developments/Updates
Table 120. SCA Pharma Basic Information, Area Served and Competitors
Table 121. SCA Pharma Major Business
Table 122. SCA Pharma 503B Compounding Pharmacies Product and Services
Table 123. SCA Pharma 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 124. 503B Compounding Pharmacies Raw Material
Table 125. Key Manufacturers of 503B Compounding Pharmacies Raw Materials
Table 126. 503B Compounding Pharmacies Typical Distributors
Table 127. 503B Compounding Pharmacies Typical Customers
Table 1. World 503B Compounding Pharmacies Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World 503B Compounding Pharmacies Market Size by Region (2017-2022) & (USD Million)
Table 3. World 503B Compounding Pharmacies Market Size by Region (2023-2028) & (USD Million)
Table 4. World 503B Compounding Pharmacies Market Size Market Share by Region (2017-2022)
Table 5. World 503B Compounding Pharmacies Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World 503B Compounding Pharmacies Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key 503B Compounding Pharmacies Players in 2021
Table 9. World 503B Compounding Pharmacies Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global 503B Compounding Pharmacies Company Evaluation Quadrant
Table 11. Head Office of Key 503B Compounding Pharmacies Player
Table 12. 503B Compounding Pharmacies Market: Company Product Type Footprint
Table 13. 503B Compounding Pharmacies Market: Company Product Application Footprint
Table 14. 503B Compounding Pharmacies Mergers & Acquisitions Activity
Table 15. United States VS China 503B Compounding Pharmacies Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of 503B Compounding Pharmacies in United States, Headquarters (States, Country)
Table 17. United States 503B Compounding Pharmacies Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States 503B Compounding Pharmacies Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of 503B Compounding Pharmacies in China, Company Headquarters (Province, Country)
Table 20. China 503B Compounding Pharmacies Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China 503B Compounding Pharmacies Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of 503B Compounding Pharmacies in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World 503B Compounding Pharmacies Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World 503B Compounding Pharmacies Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World 503B Compounding Pharmacies Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World 503B Compounding Pharmacies Revenue by Type (2017-2022) & (USD Million)
Table 27. World 503B Compounding Pharmacies Revenue by Type (2023-2028) & (USD Million)
Table 28. World 503B Compounding Pharmacies Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World 503B Compounding Pharmacies Revenue by Application (2017-2022) & (USD Million)
Table 30. World 503B Compounding Pharmacies Revenue by Application (2023-2028) & (USD Million)
Table 31. Central Admixture Pharmacy Services Basic Information, Area Served and Competitors
Table 32. Central Admixture Pharmacy Services Major Business
Table 33. Central Admixture Pharmacy Services 503B Compounding Pharmacies Product and Services
Table 34. Central Admixture Pharmacy Services 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Central Admixture Pharmacy Services Recent Developments/Updates
Table 36. Central Admixture Pharmacy Services Competitive Strengths & Weaknesses
Table 37. Nephron Pharmaceuticals Corporation Basic Information, Area Served and Competitors
Table 38. Nephron Pharmaceuticals Corporation Major Business
Table 39. Nephron Pharmaceuticals Corporation 503B Compounding Pharmacies Product and Services
Table 40. Nephron Pharmaceuticals Corporation 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Nephron Pharmaceuticals Corporation Recent Developments/Updates
Table 42. Nephron Pharmaceuticals Corporation Competitive Strengths & Weaknesses
Table 43. QuVa Pharma Basic Information, Area Served and Competitors
Table 44. QuVa Pharma Major Business
Table 45. QuVa Pharma 503B Compounding Pharmacies Product and Services
Table 46. QuVa Pharma 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. QuVa Pharma Recent Developments/Updates
Table 48. QuVa Pharma Competitive Strengths & Weaknesses
Table 49. Olympia Pharmacy Basic Information, Area Served and Competitors
Table 50. Olympia Pharmacy Major Business
Table 51. Olympia Pharmacy 503B Compounding Pharmacies Product and Services
Table 52. Olympia Pharmacy 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Olympia Pharmacy Recent Developments/Updates
Table 54. Olympia Pharmacy Competitive Strengths & Weaknesses
Table 55. ASP Cares Basic Information, Area Served and Competitors
Table 56. ASP Cares Major Business
Table 57. ASP Cares 503B Compounding Pharmacies Product and Services
Table 58. ASP Cares 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. ASP Cares Recent Developments/Updates
Table 60. ASP Cares Competitive Strengths & Weaknesses
Table 61. Fagron Compounding Pharmacies Basic Information, Area Served and Competitors
Table 62. Fagron Compounding Pharmacies Major Business
Table 63. Fagron Compounding Pharmacies 503B Compounding Pharmacies Product and Services
Table 64. Fagron Compounding Pharmacies 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Fagron Compounding Pharmacies Recent Developments/Updates
Table 66. Fagron Compounding Pharmacies Competitive Strengths & Weaknesses
Table 67. Athenex, Inc. Basic Information, Area Served and Competitors
Table 68. Athenex, Inc. Major Business
Table 69. Athenex, Inc. 503B Compounding Pharmacies Product and Services
Table 70. Athenex, Inc. 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Athenex, Inc. Recent Developments/Updates
Table 72. Athenex, Inc. Competitive Strengths & Weaknesses
Table 73. Avella Specialty Pharmacy Basic Information, Area Served and Competitors
Table 74. Avella Specialty Pharmacy Major Business
Table 75. Avella Specialty Pharmacy 503B Compounding Pharmacies Product and Services
Table 76. Avella Specialty Pharmacy 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Avella Specialty Pharmacy Recent Developments/Updates
Table 78. Avella Specialty Pharmacy Competitive Strengths & Weaknesses
Table 79. Atlas Pharmaceuticals Basic Information, Area Served and Competitors
Table 80. Atlas Pharmaceuticals Major Business
Table 81. Atlas Pharmaceuticals 503B Compounding Pharmacies Product and Services
Table 82. Atlas Pharmaceuticals 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Atlas Pharmaceuticals Recent Developments/Updates
Table 84. Atlas Pharmaceuticals Competitive Strengths & Weaknesses
Table 85. Empower Pharmacy Basic Information, Area Served and Competitors
Table 86. Empower Pharmacy Major Business
Table 87. Empower Pharmacy 503B Compounding Pharmacies Product and Services
Table 88. Empower Pharmacy 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Empower Pharmacy Recent Developments/Updates
Table 90. Empower Pharmacy Competitive Strengths & Weaknesses
Table 91. Carie Boyd’S Prescription Shop Basic Information, Area Served and Competitors
Table 92. Carie Boyd’S Prescription Shop Major Business
Table 93. Carie Boyd’S Prescription Shop 503B Compounding Pharmacies Product and Services
Table 94. Carie Boyd’S Prescription Shop 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Carie Boyd’S Prescription Shop Recent Developments/Updates
Table 96. Carie Boyd’S Prescription Shop Competitive Strengths & Weaknesses
Table 97. Edge Pharma, Imprimis NJOF Basic Information, Area Served and Competitors
Table 98. Edge Pharma, Imprimis NJOF Major Business
Table 99. Edge Pharma, Imprimis NJOF 503B Compounding Pharmacies Product and Services
Table 100. Edge Pharma, Imprimis NJOF 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Edge Pharma, Imprimis NJOF Recent Developments/Updates
Table 102. Edge Pharma, Imprimis NJOF Competitive Strengths & Weaknesses
Table 103. IntegraDose Compounding services Basic Information, Area Served and Competitors
Table 104. IntegraDose Compounding services Major Business
Table 105. IntegraDose Compounding services 503B Compounding Pharmacies Product and Services
Table 106. IntegraDose Compounding services 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. IntegraDose Compounding services Recent Developments/Updates
Table 108. IntegraDose Compounding services Competitive Strengths & Weaknesses
Table 109. Wells Pharma of Houston, LLC Basic Information, Area Served and Competitors
Table 110. Wells Pharma of Houston, LLC Major Business
Table 111. Wells Pharma of Houston, LLC 503B Compounding Pharmacies Product and Services
Table 112. Wells Pharma of Houston, LLC 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. Wells Pharma of Houston, LLC Recent Developments/Updates
Table 114. Wells Pharma of Houston, LLC Competitive Strengths & Weaknesses
Table 115. US Compounding Inc. Basic Information, Area Served and Competitors
Table 116. US Compounding Inc. Major Business
Table 117. US Compounding Inc. 503B Compounding Pharmacies Product and Services
Table 118. US Compounding Inc. 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. US Compounding Inc. Recent Developments/Updates
Table 120. SCA Pharma Basic Information, Area Served and Competitors
Table 121. SCA Pharma Major Business
Table 122. SCA Pharma 503B Compounding Pharmacies Product and Services
Table 123. SCA Pharma 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 124. 503B Compounding Pharmacies Raw Material
Table 125. Key Manufacturers of 503B Compounding Pharmacies Raw Materials
Table 126. 503B Compounding Pharmacies Typical Distributors
Table 127. 503B Compounding Pharmacies Typical Customers
LIST OF FIGURES
Figure 1. 503B Compounding Pharmacies Picture
Figure 2. World 503B Compounding Pharmacies Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World 503B Compounding Pharmacies Total Market Size (2017-2028) & (USD Million)
Figure 4. World 503B Compounding Pharmacies Market Size Market Share by Region (2017-2028)
Figure 5. United States 503B Compounding Pharmacies Market Size (2017-2028) & (USD Million)
Figure 6. China 503B Compounding Pharmacies Market Size (2017-2028) & (USD Million)
Figure 7. Europe 503B Compounding Pharmacies Market Size (2017-2028) & (USD Million)
Figure 8. Japan 503B Compounding Pharmacies Market Size (2017-2028) & (USD Million)
Figure 9. South Korea 503B Compounding Pharmacies Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN 503B Compounding Pharmacies Market Size (2017-2028) & (USD Million)
Figure 11. India 503B Compounding Pharmacies Market Size (2017-2028) & (USD Million)
Figure 12. 503B Compounding Pharmacies Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of 503B Compounding Pharmacies by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for 503B Compounding Pharmacies Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for 503B Compounding Pharmacies Markets in 2021
Figure 17. United States VS China: 503B Compounding Pharmacies Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World 503B Compounding Pharmacies Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World 503B Compounding Pharmacies Market Size Market Share by Type in 2021
Figure 20. Acetaminophen
Figure 21. Phenylephrine
Figure 22. Midazolam
Figure 23. Esmolol
Figure 24. Vancomycin
Figure 25. Epinephrine
Figure 26. Adenocaine
Figure 27. Fentanyl/ Bupivacaine
Figure 28. Morphine
Figure 29. Other
Figure 30. World 503B Compounding Pharmacies Market Size Market Share by Type (2017-2028)
Figure 31. World 503B Compounding Pharmacies Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 32. World 503B Compounding Pharmacies Market Size Market Share by Application in 2021
Figure 33. On-line
Figure 34. Offline
Figure 35. World 503B Compounding Pharmacies Market Size Market Share by Application (2017-2028)
Figure 36. Manufacturing Cost Structure Analysis of 503B Compounding Pharmacies in 2021
Figure 37. Manufacturing Process Analysis of 503B Compounding Pharmacies
Figure 38. 503B Compounding Pharmacies Industrial Chain
Figure 39. Distribution Channel Breakdown for 503B Compounding Pharmacies Shipments (%): 2017-2028
Figure 40. Direct Channel Pros & Cons
Figure 41. Indirect Channel Pros & Cons
Figure 42. Methodology
Figure 43. Research Process and Data Source
Figure 1. 503B Compounding Pharmacies Picture
Figure 2. World 503B Compounding Pharmacies Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World 503B Compounding Pharmacies Total Market Size (2017-2028) & (USD Million)
Figure 4. World 503B Compounding Pharmacies Market Size Market Share by Region (2017-2028)
Figure 5. United States 503B Compounding Pharmacies Market Size (2017-2028) & (USD Million)
Figure 6. China 503B Compounding Pharmacies Market Size (2017-2028) & (USD Million)
Figure 7. Europe 503B Compounding Pharmacies Market Size (2017-2028) & (USD Million)
Figure 8. Japan 503B Compounding Pharmacies Market Size (2017-2028) & (USD Million)
Figure 9. South Korea 503B Compounding Pharmacies Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN 503B Compounding Pharmacies Market Size (2017-2028) & (USD Million)
Figure 11. India 503B Compounding Pharmacies Market Size (2017-2028) & (USD Million)
Figure 12. 503B Compounding Pharmacies Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of 503B Compounding Pharmacies by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for 503B Compounding Pharmacies Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for 503B Compounding Pharmacies Markets in 2021
Figure 17. United States VS China: 503B Compounding Pharmacies Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World 503B Compounding Pharmacies Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World 503B Compounding Pharmacies Market Size Market Share by Type in 2021
Figure 20. Acetaminophen
Figure 21. Phenylephrine
Figure 22. Midazolam
Figure 23. Esmolol
Figure 24. Vancomycin
Figure 25. Epinephrine
Figure 26. Adenocaine
Figure 27. Fentanyl/ Bupivacaine
Figure 28. Morphine
Figure 29. Other
Figure 30. World 503B Compounding Pharmacies Market Size Market Share by Type (2017-2028)
Figure 31. World 503B Compounding Pharmacies Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 32. World 503B Compounding Pharmacies Market Size Market Share by Application in 2021
Figure 33. On-line
Figure 34. Offline
Figure 35. World 503B Compounding Pharmacies Market Size Market Share by Application (2017-2028)
Figure 36. Manufacturing Cost Structure Analysis of 503B Compounding Pharmacies in 2021
Figure 37. Manufacturing Process Analysis of 503B Compounding Pharmacies
Figure 38. 503B Compounding Pharmacies Industrial Chain
Figure 39. Distribution Channel Breakdown for 503B Compounding Pharmacies Shipments (%): 2017-2028
Figure 40. Direct Channel Pros & Cons
Figure 41. Indirect Channel Pros & Cons
Figure 42. Methodology
Figure 43. Research Process and Data Source
